Funder Information Declared References 1. 2. 3. 4
647 Gallic acid inhibits ferroptosis in spinal microglia by regulating the P2X7-ROS signaling pathway, alleviates pain in rats, and reverses the CCI-induced increase in iron concentration and mitochondrial damage
However, as with any intravenous or injectable therapy, there are important considerations to keep in mind: NAD+ IV therapy is generally considered investigational for many of its applications and is not approved by the FDA for the treatment, prevention, or cure of any disease Side effects, though typically mild, can include nausea, flushing, dizziness, or discomfort related to infusion rate Patients with kidney or liver concerns, or those taking specific medications, should discuss these factors with their provider before starting NAD+ therapy is not a substitute for conventional medical treatment for diagnosed conditions Baseline blood testing is recommended before beginning any new IV or injectable protocol at RWACenter At Robertson Wellness & Aesthetics, every NAD+ therapy protocol is conducted under the supervision of trained healthcare professionals
accelerated closure rates TB-500 : 42-61% increased reepithelialization in full-thickness wounds
